Henry Gomez

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.

Lajos Pusztai, Christos Sotiriou, Kenneth R Hess, 2007, The Lancet. Oncology.

Planning cancer control in Latin America and the Caribbean.

Richard Sullivan, Eduardo Cazap, Eduardo Rosenblatt, 2013, The Lancet. Oncology.

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Yuan Qi, W. Fraser Symmans, Lajos Pusztai, 2012, Breast Cancer Research and Treatment.

Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer

Yuan Qi, W. Fraser Symmans, Lajos Pusztai, 2010, Clinical Cancer Research.